Loading…

Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis

Injury and loss of the endothelial glycocalyx occur during the early phase of sepsis. We previously showed that antithrombin has a protective effect on this structure in vitro. Here, we investigated the possible protective effects of antithrombin in an animal model of sepsis. Wistar rats were inject...

Full description

Saved in:
Bibliographic Details
Published in:Thrombosis research 2018-11, Vol.171, p.1-6
Main Authors: Iba, Toshiaki, Levy, Jerrold H., Hirota, Tatsuhiko, Hiki, Makoto, Sato, Koichi, Murakami, Taisuke, Nagaoka, Isao
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33
cites cdi_FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33
container_end_page 6
container_issue
container_start_page 1
container_title Thrombosis research
container_volume 171
creator Iba, Toshiaki
Levy, Jerrold H.
Hirota, Tatsuhiko
Hiki, Makoto
Sato, Koichi
Murakami, Taisuke
Nagaoka, Isao
description Injury and loss of the endothelial glycocalyx occur during the early phase of sepsis. We previously showed that antithrombin has a protective effect on this structure in vitro. Here, we investigated the possible protective effects of antithrombin in an animal model of sepsis. Wistar rats were injected with endotoxin, and circulating levels of syndecan-1, hyaluronan, albumin, lactate and other biomarkers were measured in an antithrombin-treated group and an untreated control group (n = 6 in each group). Intravital microscopy was used to observe leukocyte adhesion, microcirculation, and syndecan-1 staining. The circulating levels of syndecan-1 and hyaluronan were significantly reduced in the antithrombin-treated group, compared with the untreated controls. Lactate levels and albumin reduction were significantly attenuated in the antithrombin-treated group. Intravital microscopic observation revealed that both leukocyte adhesion and blood flow were better maintained in the treatment group. The syndecan-1 lining was disrupted after endotoxin treatment, and this derangement was attenuated by treatment with antithrombin. Antithrombin effectively maintained microcirculation and vascular integrity by protecting the glycocalyx in a rat sepsis model. [Display omitted]
doi_str_mv 10.1016/j.thromres.2018.09.042
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2105051592</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0049384818305267</els_id><sourcerecordid>2105051592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33</originalsourceid><addsrcrecordid>eNqFkMtuFDEQRS1ERCaPX4i8ZNNNlftl70ARAaRIsCBry21XE4-67cHuQZm_x8MkbCOVVJtz66oOYzcINQL2H7b1-pjikijXAlDWoGpoxRu2QTmoSrSDeMs2AK2qGtnKc3aR8xYAB1TdO3begMBeCtww9yPFlezqY-Bx4usjcQoulj17M_Nf88FGa-bDEx8P3ITV_6sdfeBlTDjB8cmHyge3t-R4MitfoqP5eC_TLvt8xc4mM2e6ft6X7OHu88_br9X99y_fbj_dV7btYa2GRpCYlEQhBmddZ4XEqUMnnW1olOPoJhRoTE_CNAYEKJIKre161w_WNc0le3-6u0vx957yqhefLc2zCRT3WQuEDjrslChof0JtijknmvQu-cWkg0bQR8N6q18M66NhDUoXwyV489yxHxdy_2MvSgvw8QRQ-fSPp6Sz9RSKGp-KaO2if63jL0xjkpA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2105051592</pqid></control><display><type>article</type><title>Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Iba, Toshiaki ; Levy, Jerrold H. ; Hirota, Tatsuhiko ; Hiki, Makoto ; Sato, Koichi ; Murakami, Taisuke ; Nagaoka, Isao</creator><creatorcontrib>Iba, Toshiaki ; Levy, Jerrold H. ; Hirota, Tatsuhiko ; Hiki, Makoto ; Sato, Koichi ; Murakami, Taisuke ; Nagaoka, Isao</creatorcontrib><description>Injury and loss of the endothelial glycocalyx occur during the early phase of sepsis. We previously showed that antithrombin has a protective effect on this structure in vitro. Here, we investigated the possible protective effects of antithrombin in an animal model of sepsis. Wistar rats were injected with endotoxin, and circulating levels of syndecan-1, hyaluronan, albumin, lactate and other biomarkers were measured in an antithrombin-treated group and an untreated control group (n = 6 in each group). Intravital microscopy was used to observe leukocyte adhesion, microcirculation, and syndecan-1 staining. The circulating levels of syndecan-1 and hyaluronan were significantly reduced in the antithrombin-treated group, compared with the untreated controls. Lactate levels and albumin reduction were significantly attenuated in the antithrombin-treated group. Intravital microscopic observation revealed that both leukocyte adhesion and blood flow were better maintained in the treatment group. The syndecan-1 lining was disrupted after endotoxin treatment, and this derangement was attenuated by treatment with antithrombin. Antithrombin effectively maintained microcirculation and vascular integrity by protecting the glycocalyx in a rat sepsis model. [Display omitted]</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/j.thromres.2018.09.042</identifier><identifier>PMID: 30216821</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Animals ; Antithrombin ; Antithrombin Proteins - therapeutic use ; Antithrombins - therapeutic use ; Endothelium ; Endothelium, Vascular - drug effects ; Endothelium, Vascular - immunology ; Endothelium, Vascular - pathology ; Endotoxins - immunology ; Glycocalyx - drug effects ; Glycocalyx - immunology ; Glycocalyx - pathology ; Hyaluronan ; Hyaluronic Acid - blood ; Hyaluronic Acid - immunology ; Inflammation ; Inflammation - blood ; Inflammation - drug therapy ; Inflammation - immunology ; Inflammation - pathology ; Microcirculation ; Microcirculation - drug effects ; Rats, Wistar ; Sepsis ; Sepsis - blood ; Sepsis - drug therapy ; Sepsis - immunology ; Sepsis - pathology ; Syndecan-1 ; Syndecan-1 - blood ; Syndecan-1 - immunology</subject><ispartof>Thrombosis research, 2018-11, Vol.171, p.1-6</ispartof><rights>2018 Elsevier Ltd</rights><rights>Copyright © 2018 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33</citedby><cites>FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33</cites><orcidid>0000-0002-0255-4088</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30216821$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iba, Toshiaki</creatorcontrib><creatorcontrib>Levy, Jerrold H.</creatorcontrib><creatorcontrib>Hirota, Tatsuhiko</creatorcontrib><creatorcontrib>Hiki, Makoto</creatorcontrib><creatorcontrib>Sato, Koichi</creatorcontrib><creatorcontrib>Murakami, Taisuke</creatorcontrib><creatorcontrib>Nagaoka, Isao</creatorcontrib><title>Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>Injury and loss of the endothelial glycocalyx occur during the early phase of sepsis. We previously showed that antithrombin has a protective effect on this structure in vitro. Here, we investigated the possible protective effects of antithrombin in an animal model of sepsis. Wistar rats were injected with endotoxin, and circulating levels of syndecan-1, hyaluronan, albumin, lactate and other biomarkers were measured in an antithrombin-treated group and an untreated control group (n = 6 in each group). Intravital microscopy was used to observe leukocyte adhesion, microcirculation, and syndecan-1 staining. The circulating levels of syndecan-1 and hyaluronan were significantly reduced in the antithrombin-treated group, compared with the untreated controls. Lactate levels and albumin reduction were significantly attenuated in the antithrombin-treated group. Intravital microscopic observation revealed that both leukocyte adhesion and blood flow were better maintained in the treatment group. The syndecan-1 lining was disrupted after endotoxin treatment, and this derangement was attenuated by treatment with antithrombin. Antithrombin effectively maintained microcirculation and vascular integrity by protecting the glycocalyx in a rat sepsis model. [Display omitted]</description><subject>Animals</subject><subject>Antithrombin</subject><subject>Antithrombin Proteins - therapeutic use</subject><subject>Antithrombins - therapeutic use</subject><subject>Endothelium</subject><subject>Endothelium, Vascular - drug effects</subject><subject>Endothelium, Vascular - immunology</subject><subject>Endothelium, Vascular - pathology</subject><subject>Endotoxins - immunology</subject><subject>Glycocalyx - drug effects</subject><subject>Glycocalyx - immunology</subject><subject>Glycocalyx - pathology</subject><subject>Hyaluronan</subject><subject>Hyaluronic Acid - blood</subject><subject>Hyaluronic Acid - immunology</subject><subject>Inflammation</subject><subject>Inflammation - blood</subject><subject>Inflammation - drug therapy</subject><subject>Inflammation - immunology</subject><subject>Inflammation - pathology</subject><subject>Microcirculation</subject><subject>Microcirculation - drug effects</subject><subject>Rats, Wistar</subject><subject>Sepsis</subject><subject>Sepsis - blood</subject><subject>Sepsis - drug therapy</subject><subject>Sepsis - immunology</subject><subject>Sepsis - pathology</subject><subject>Syndecan-1</subject><subject>Syndecan-1 - blood</subject><subject>Syndecan-1 - immunology</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqFkMtuFDEQRS1ERCaPX4i8ZNNNlftl70ARAaRIsCBry21XE4-67cHuQZm_x8MkbCOVVJtz66oOYzcINQL2H7b1-pjikijXAlDWoGpoxRu2QTmoSrSDeMs2AK2qGtnKc3aR8xYAB1TdO3begMBeCtww9yPFlezqY-Bx4usjcQoulj17M_Nf88FGa-bDEx8P3ITV_6sdfeBlTDjB8cmHyge3t-R4MitfoqP5eC_TLvt8xc4mM2e6ft6X7OHu88_br9X99y_fbj_dV7btYa2GRpCYlEQhBmddZ4XEqUMnnW1olOPoJhRoTE_CNAYEKJIKre161w_WNc0le3-6u0vx957yqhefLc2zCRT3WQuEDjrslChof0JtijknmvQu-cWkg0bQR8N6q18M66NhDUoXwyV489yxHxdy_2MvSgvw8QRQ-fSPp6Sz9RSKGp-KaO2if63jL0xjkpA</recordid><startdate>20181101</startdate><enddate>20181101</enddate><creator>Iba, Toshiaki</creator><creator>Levy, Jerrold H.</creator><creator>Hirota, Tatsuhiko</creator><creator>Hiki, Makoto</creator><creator>Sato, Koichi</creator><creator>Murakami, Taisuke</creator><creator>Nagaoka, Isao</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0255-4088</orcidid></search><sort><creationdate>20181101</creationdate><title>Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis</title><author>Iba, Toshiaki ; Levy, Jerrold H. ; Hirota, Tatsuhiko ; Hiki, Makoto ; Sato, Koichi ; Murakami, Taisuke ; Nagaoka, Isao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Antithrombin</topic><topic>Antithrombin Proteins - therapeutic use</topic><topic>Antithrombins - therapeutic use</topic><topic>Endothelium</topic><topic>Endothelium, Vascular - drug effects</topic><topic>Endothelium, Vascular - immunology</topic><topic>Endothelium, Vascular - pathology</topic><topic>Endotoxins - immunology</topic><topic>Glycocalyx - drug effects</topic><topic>Glycocalyx - immunology</topic><topic>Glycocalyx - pathology</topic><topic>Hyaluronan</topic><topic>Hyaluronic Acid - blood</topic><topic>Hyaluronic Acid - immunology</topic><topic>Inflammation</topic><topic>Inflammation - blood</topic><topic>Inflammation - drug therapy</topic><topic>Inflammation - immunology</topic><topic>Inflammation - pathology</topic><topic>Microcirculation</topic><topic>Microcirculation - drug effects</topic><topic>Rats, Wistar</topic><topic>Sepsis</topic><topic>Sepsis - blood</topic><topic>Sepsis - drug therapy</topic><topic>Sepsis - immunology</topic><topic>Sepsis - pathology</topic><topic>Syndecan-1</topic><topic>Syndecan-1 - blood</topic><topic>Syndecan-1 - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iba, Toshiaki</creatorcontrib><creatorcontrib>Levy, Jerrold H.</creatorcontrib><creatorcontrib>Hirota, Tatsuhiko</creatorcontrib><creatorcontrib>Hiki, Makoto</creatorcontrib><creatorcontrib>Sato, Koichi</creatorcontrib><creatorcontrib>Murakami, Taisuke</creatorcontrib><creatorcontrib>Nagaoka, Isao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iba, Toshiaki</au><au>Levy, Jerrold H.</au><au>Hirota, Tatsuhiko</au><au>Hiki, Makoto</au><au>Sato, Koichi</au><au>Murakami, Taisuke</au><au>Nagaoka, Isao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2018-11-01</date><risdate>2018</risdate><volume>171</volume><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>Injury and loss of the endothelial glycocalyx occur during the early phase of sepsis. We previously showed that antithrombin has a protective effect on this structure in vitro. Here, we investigated the possible protective effects of antithrombin in an animal model of sepsis. Wistar rats were injected with endotoxin, and circulating levels of syndecan-1, hyaluronan, albumin, lactate and other biomarkers were measured in an antithrombin-treated group and an untreated control group (n = 6 in each group). Intravital microscopy was used to observe leukocyte adhesion, microcirculation, and syndecan-1 staining. The circulating levels of syndecan-1 and hyaluronan were significantly reduced in the antithrombin-treated group, compared with the untreated controls. Lactate levels and albumin reduction were significantly attenuated in the antithrombin-treated group. Intravital microscopic observation revealed that both leukocyte adhesion and blood flow were better maintained in the treatment group. The syndecan-1 lining was disrupted after endotoxin treatment, and this derangement was attenuated by treatment with antithrombin. Antithrombin effectively maintained microcirculation and vascular integrity by protecting the glycocalyx in a rat sepsis model. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>30216821</pmid><doi>10.1016/j.thromres.2018.09.042</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-0255-4088</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0049-3848
ispartof Thrombosis research, 2018-11, Vol.171, p.1-6
issn 0049-3848
1879-2472
language eng
recordid cdi_proquest_miscellaneous_2105051592
source ScienceDirect Freedom Collection 2022-2024
subjects Animals
Antithrombin
Antithrombin Proteins - therapeutic use
Antithrombins - therapeutic use
Endothelium
Endothelium, Vascular - drug effects
Endothelium, Vascular - immunology
Endothelium, Vascular - pathology
Endotoxins - immunology
Glycocalyx - drug effects
Glycocalyx - immunology
Glycocalyx - pathology
Hyaluronan
Hyaluronic Acid - blood
Hyaluronic Acid - immunology
Inflammation
Inflammation - blood
Inflammation - drug therapy
Inflammation - immunology
Inflammation - pathology
Microcirculation
Microcirculation - drug effects
Rats, Wistar
Sepsis
Sepsis - blood
Sepsis - drug therapy
Sepsis - immunology
Sepsis - pathology
Syndecan-1
Syndecan-1 - blood
Syndecan-1 - immunology
title Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T08%3A16%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protection%20of%20the%20endothelial%20glycocalyx%20by%20antithrombin%20in%20an%20endotoxin-induced%20rat%20model%20of%20sepsis&rft.jtitle=Thrombosis%20research&rft.au=Iba,%20Toshiaki&rft.date=2018-11-01&rft.volume=171&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/j.thromres.2018.09.042&rft_dat=%3Cproquest_cross%3E2105051592%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c460t-732e2f981227dcd5c281f51d8dc3eb8bbdf121aa6e2a3a0209e891cc56d67cd33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2105051592&rft_id=info:pmid/30216821&rfr_iscdi=true